BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 24, 2002
View Archived Issues
Bayer Buying Pharmacogenomics Firm Visible Genetics For $61.4M
Bayer Corp. is scooping up Visible Genetics Inc. for $61.4 million in cash as the parties signed a definitive agreement for a deal that brings to Bayer VGI's Trugene HIV-1 Genotyping Kit and OpenGene DNA Sequencing System. (Bioworld Today)
Read More
ICOS, Texas Biotechnology Stop Phase IIb/III Extension
Read More
Microarray Profiling Reveals Gene Dots Connecting Lung Carcinoma, Tumor Excision, Odds On Survival
Read More
Corvas Cuts 40 Percent Of Staff, Focuses On Late-Stage Products
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More